Comments on: HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui https://insideout.vn/hutchmed-initiates-phase-ii-iii-trial-of-the-combination-of-surufatinib-and-camrelizumab-for-treatment-naive-pancreatic-ductal-adenocarcinoma-in-collaboration-with-hengrui/ Inside Out Tue, 14 May 2024 00:00:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2